An ACE inhibitor (Ramipril) was added to the treatment plan because of persistence of hypertension and erythrocytosis; response was initially poor, but eighteen months after the start of Ramipril treatment Hct and Hb levels returned to normal, and no further phlebotomy or erythroapheresis were required. This evidence concerns the gene GSTM1 and hypertensive disorder.